Continue to Site »
Site will load in 15 seconds

Continue to Site »X

Advertisment: Pipp Horticulture » PIPP Order 87 » CBT ROS 500x500 Lightbox August 2025 » 500x500-Lightbox-Timing-Your-Veg

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

Kris

Michelle Simakis

December 23, 2022

Cannabis Business Times Editor Theresa Bennett, Senior Editor Zach Mentz, Associate Editor Andriana Ruscitto, and Managing Editor Patrick Williams contributed to this report, which was originally published online Oct. 26, 2022. Read the original, extended version here.

Log in to view the full article

US Congressman Vows to File 1-to-3 Act to Reschedule Cannabis

Trump Publicly Addresses Cannabis Rescheduling: Decision Coming in ‘Next Few Weeks’

With DEA Head in Place, Trump Now Ready to ‘Look at’ Cannabis Rescheduling

ICE Raids, Texas Hemp THC Ban, Federal Bills Lead CBT Top Stories in July

US Congressman Vows to File 1-to-3 Act to Reschedule Cannabis

Republican Rep. Greg Steube said he will reintroduce legislation to move cannabis to Schedule III on the heels of Trump’s public comments.

U.S. House Rep. Greg Steube, R-Fla.

Trump Publicly Addresses Cannabis Rescheduling: Decision Coming in ‘Next Few Weeks’

President Donald Trump reaffirmed media reports that his administration is ‘looking at’ loosening federal restrictions on cannabis.

President Donald Trump turns to Attorney General Pam Bondi during an Aug. 11 White House press conference, when saying that a cannabis rescheduling decision will come 'over the next few weeks.'

With DEA Head in Place, Trump Now Ready to ‘Look at’ Cannabis Rescheduling

The president reportedly said in private conversations and donor events that he’s considering loosening the federal restrictions on cannabis.

Donald Trump Portrait Merged

ICE Raids, Texas Hemp THC Ban, Federal Bills Lead CBT Top Stories in July

The raids at Glass House and Texas’ pursuit to prohibit intoxicating hemp products remain ongoing storylines, as US lawmakers try to block rescheduling.

Top10 July2025

Trump’s New DEA Administrator Omits Cannabis Rescheduling From Top Priorities

Terrance Cole did not include rescheduling among his eight strategic priorities upon being sworn in, a U-turn from his confirmation hearing.

U.S. Attorney General Pam Bondi (left) and DEA Administrator Terry Cole during Cole's swearing-in on July 23.

DEA Judge Overseeing Cannabis Rescheduling Hearing Set to Retire

John J. Mulrooney, the Drug Enforcement Administration’s chief administrative law judge, is retiring from the bench on Aug. 1.

DEA Chief Administrative Law Judge John J. Mulrooney II is set to retire Aug. 1.

Cannabis Industry Stakeholders React to DEA Head Terrance Cole’s Confirmation

Proponents of cannabis rescheduling, and more broadly descheduling, are hoping Cole ‘listens to the experts’ and ‘follows the science.’

Mj grow 243589890

UPDATE: US Senate Confirms Trump’s DEA Administrator Pick

After the Senate invoked cloture, Terrance Cole was confirmed as the Drug Enforcement Administration’s next leader.

Terry Cole, Trump’s nominee to lead the DEA, testifies during his Senate Judiciary Committee confirmation hearing on April 30.

US House Subcommittee Advances Bill to Prevent Cannabis Rescheduling Under DOJ

The House appropriations bill would block the Department of Justice from using funds to reschedule or deschedule cannabis.

U.S. House Commerce, Justice and Science (CJS) Subcommittee Chairman Hal Rogers, R-Ky., oversees a spending bill markup on July 15.

DEA Provides No Cannabis Rescheduling Update After 180 Days

The Drug Enforcement Administration still has yet to fix a briefing schedule for an interlocutory appeal as Trump’s nominee awaits Senate confirmation.

American Cannabis 679861553

2 Senate Democrats Press Likely DEA Head on Cannabis Rescheduling Stance

Terry Cole, Trump’s nominee to lead the Drug Enforcement Administration, said he would provide 'careful consideration' to the rescheduling matter.

Dea 682322766 Editorial Use Only

DEA’s Likely Administrator Refuses to Commit to Schedule III Proposal for Cannabis

Terry Cole said at his nomination hearing that he’ll move the hearing process forward, but he needs to know more about the science behind the proposal.

Terry Cole, Trump’s nominee to lead the DEA, testifies during his Senate Judiciary Committee confirmation hearing on April 30.

Page 1 of 13